FK Biotecnologia
Porto Alegre, Rio Grande do Sul, Brazil
About FK Biotecnologia
FK Biotecnologia manufactures biotech-based products. Its products include antibodies, equipment, labware, and reagents and solutions; and services comprise antibody development, lateral flow and flow through test development, Elisa tests development, antibody purification and conjugation, and antibody isotyping. FK Biotecnologia also offers therapeutic peptides for the treatment of neurological diseases such as Alzheimer, oncology, obesity, and inflammatory diseases, recombinant proteins, biosensors to detect glucose, urea, and other enzymes, and bioinsecticide for agriculture, public health, and household uses. It also provides its products for the diagnostic of HCG, HIV, dengue, and other infectious diseases; early detection of cancer; and nanotechnology. FK Biotecnologia began operation in 1999. It has its headquarters in Porto Alegre in Brazil.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $338.7K
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2000)
- Website: fkbiotech.com
- Phone: 55 51 3352 6864
Industries & Categories
Biotechnology, Emergency Medicine, Health Care, Nanotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/fk-biotecnologia-2573942 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.